Metdose GP 1mg/500mg/15mg Tablet SR
Marketer
Medxone Healthcare
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Metdose GP 1mg/500mg/15mg Tablet SR
Glimepiride/Metformin/Pioglitazone extended-release tablets (1mg/500mg/15mg) are a triple-combination medication designed to manage elevated blood glucose. This therapy, used alongside a healthy diet and regular exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, resulting in reduced blood sugar. Adhere strictly to your physician's prescribed dosage and regimen. Ingestion with food minimizes gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; in that case, omit the missed dose and resume the regular schedule. Never double the dose. An overdose can cause dangerously low blood sugar (hypoglycemia). Concomitant use with other diabetes medications, alcohol consumption, or skipped meals increases the risk of hypoglycemia. Regular blood glucose monitoring is crucial. Common adverse effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to initiating treatment, disclose any existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function will be assessed before commencing therapy. Limit alcohol consumption to mitigate potential side effects.
Uses of Metdose GP 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Metdose GP 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metdose GP 1mg/500mg/15mg Extended-Release tablet should be administered with a meal.
Common Side effects of Metdose GP 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Metdose GP 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet; avoid crushing, chewing, or fracturing it. The Metdose GP 1mg/500mg/15mg Extended-Release tablet should be administered with a meal.
How Metdose GP 1mg/500mg/15mg Tablet SR works:
Metdose GP SR tablets (1mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Metdose GP 1mg/500mg/15mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Metdose GP 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers before recommending this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Metdose GP 1mg/500mg/15mg tablet's use while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Metdose GP 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when using Metdose GP 1mg/500mg/15mg SR tablets, as dosage modification may be necessary. Individuals with severe hepatic dysfunction should avoid this medication; physician consultation is advised.
What if you forget to take Metdose GP 1mg/500mg/15mg Tablet SR :
Should you forget a Metdose GP 1mg/500mg/15mg SR Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metdose GP 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently